Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BeiGene, Ltd.
  6. Consensus
    BGNE   US07725L1026

BEIGENE, LTD.

(BGNE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on BEIGENE, LTD.
Target Price consensus revisions : last 18 months
Recommendations (Chart) BEIGENE, LTD.
Analyst Recommendations on BEIGENE, LTD.
05/09Morgan Stanley Lowers BeiGene's Price Target to $300 From $338, Maintains Overweight Ratin..
MT
04/12Morgan Stanley Adjusts BeiGene's Price Target to $338 from $330, Keeps Overweight Rating
MT
03/17SVB Leerink Cuts BeiGene to Market Perform From Outperform, Price Target to $177 From $300
MT
03/01Nomura Upgrades BeiGene to Buy From Neutral, Adjusts Price Target to $310.62 From $293.28
MT
03/01Nomura Upgrades BeiGene to Buy From Neutral, Adjusts Price Target to HK$186.85 From HK$176..
MT
02/28Macquarie Lowers BeiGene's Price Target to $301.60 From $312.80, Maintains Outperform Rati..
MT
02/28Morgan Stanley Lowers BeiGene's Price Target to $330 From $360, Maintains Overweight Ratin..
MT
More recommendations
Analysis
Exclusive - Chinese regulators ask some U.S.-listed firms to prepare for audit disclosures - sources
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 16
Last Close Price 131,09 $
Average target price 309,79 $
Spread / Average Target 136%
High Price Target 470,00 $
Spread / Highest target 259%
Low Price Target 177,00 $
Spread / Lowest Target 35,0%
Consensus detail
Consensus revision (last 18 months)